Dean E. Carter - Publications

Affiliations: 
University of Arizona, Tucson, AZ 
Area:
Environmental Sciences, Toxicology, Microbiology Biology

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Peraza MA, Carter DE, Gandolfi AJ. Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2). Cell Biology and Toxicology. 19: 253-64. PMID 14686617 DOI: 10.1023/B:Cbto.0000003970.60896.49  0.349
2003 Carter DE, Aposhian HV, Gandolfi AJ. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicology and Applied Pharmacology. 193: 309-34. PMID 14678742 DOI: 10.1016/J.Taap.2003.07.009  0.332
2000 Ayala-Fierro F, Carter DE. LLC-PK1 cells as a model for renal toxicity caused by arsine exposure Journal of Toxicology and Environmental Health - Part A. 60: 67-79. PMID 10832618 DOI: 10.1080/009841000156592  0.363
2000 Rael LT, Ayala-Fierro F, Carter DE. The effects of sulfur, thiol, and thiol inhibitor compounds on arsine- induced toxicity in the human erythrocyte membrane Toxicological Sciences. 55: 468-477. PMID 10828280 DOI: 10.1093/Toxsci/55.2.468  0.311
2000 Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicology and Applied Pharmacology. 163: 203-7. PMID 10698679 DOI: 10.1006/Taap.1999.8872  0.346
2000 Mitchell RD, Ayala-Fierro F, Carter DE. Systemic indicators of inorganic arsenic toxicity in four animal species Journal of Toxicology and Environmental Health - Part A. 59: 119-134. PMID 10653439 DOI: 10.1080/009841000157014  0.397
2000 Ayala-Fierro F, Baldwin AL, Wilson LM, Valeski JE, Carter DE. Structural alterations in the rat kidney after acute arsine exposure Laboratory Investigation. 80: 87-97. PMID 10653007 DOI: 10.1038/Labinvest.3780012  0.368
1999 Ayala-Fierro F, Barber DS, Rael LT, Carter DE. In vitro tissue specificity for arsine and arsenite toxicity in the rat Toxicological Sciences. 52: 122-129. PMID 10568705 DOI: 10.1093/Toxsci/52.1.122  0.383
1999 Ayala-Fierro F, Firriolo JM, Carter DE. Disposition, toxicity, and intestinal absorption of cobaltous chloride in male Fischer 344 rats Journal of Toxicology and Environmental Health - Part A. 56: 571-591. PMID 10321386 DOI: 10.1080/00984109909350178  0.357
1997 Winski SL, Barber DS, Rael LT, Carter DE. Sequence of toxic events in arsine-induced hemolysis in vitro: Implications for the mechanism of toxicity in human erythrocytes Fundamental and Applied Toxicology. 38: 123-128. PMID 9299185 DOI: 10.1006/Faat.1997.2339  0.364
1995 Hatlelid KM, Brailsford C, Carter DE. An in vitro model for arsine toxicity using isolated red blood cells Fundamental and Applied Toxicology. 25: 302-306. PMID 7545139 DOI: 10.1006/Faat.1995.1066  0.351
1995 Lantz RC, Parliman G, Guan Jie Chen, Barber D, Winski S, Carter DE. Effect of arsenic exposure on alveolar macrophage function. II. Effect of slightly soluble forms of As(III) and As(V) Environmental Research. 68: 59-67. PMID 7537211 DOI: 10.1006/Enrs.1995.1008  0.36
1995 Winski SL, Carter DE. Interactions of rat red blood cell sulfhydryls with arsenate and arsenite Journal of Toxicology and Environmental Health. 46: 379-397. PMID 7473865 DOI: 10.1080/15287399509532043  0.362
1994 Zheng W, Winter SM, Kattnig MJ, Carter DE, Glenn Sipes I. Tissue distribution and elimination of indium in male fischer 344 rats following oral and intratracheal administration of indium phosphide Journal of Toxicology and Environmental Health. 43: 483-494. PMID 7990172 DOI: 10.1080/15287399409531936  0.384
1993 Scott N, Hatlelid KM, MacKenzie NE, Carter DE. Reactions of arsenic(III) and arsenic(V) species with glutathione Chemical Research in Toxicology. 6: 102-106. PMID 8448339 DOI: 10.1021/Tx00031A016  0.327
1992 Aposhian HV, Maiorino RM, Rivera M, Bruce DC, Dart RC, Hurlbut KM, Levine DJ, Zheng W, Fernando Q, Carter D. Human studies with the chelating agents, DMPS and DMSA. Journal of Toxicology. Clinical Toxicology. 30: 505-28. PMID 1331491 DOI: 10.3109/15563659209017938  0.367
1990 Smith BJ, Carter DE, Sipes IG. Comparison of the disposition and in vitro metabolism of 4-vinylcyclohexene in the female mouse and rat Toxicology and Applied Pharmacology. 105: 364-371. PMID 2237911 DOI: 10.1016/0041-008X(90)90140-P  0.371
1989 Elsisi AE, Carter DE, Sipes IG. Dermal absorption of phthalate diesters in rats. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 12: 70-7. PMID 2925020 DOI: 10.1016/0272-0590(89)90063-8  0.385
1988 Lucek RW, Dickerson J, Carter DE, Bugge CJL, Crews T, Vane FM, Cunningham W, Colburn WA. Pharmacokinetics of 14C-etretinate in healthy volunteers and two patients with biliary T-tube drainage Biopharmaceutics and Drug Disposition. 9: 487-499. PMID 3066416 DOI: 10.1002/Bod.2510090507  0.317
1987 Rosner MH, Carter DE. Metabolism and excretion of gallium arsenide and arsenic oxides by hamsters following intratracheal instillation Fundamental and Applied Toxicology. 9: 730-737. PMID 3692028 DOI: 10.1016/0272-0590(87)90180-1  0.371
1986 Webb DR, Wilson SE, Carter DE. Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide, or arsenic(III) oxide intratracheally instilled into rats Toxicology and Applied Pharmacology. 82: 405-416. PMID 3952726 DOI: 10.1016/0041-008X(86)90276-0  0.367
1986 Roby MR, Carle S, Pereira MA, Carter DE. Excretion and tissue disposition of dichloroacetonitrile in rats and mice Environmental Health Perspectives. 215-220. PMID 3816725 DOI: 10.1289/Ehp.8669215  0.308
1986 Eigenberg DA, Carter DE, Schram KH, Sipes IG. Examination of the differential hepatotoxicity of diallyl phthalate in rats and mice Toxicology and Applied Pharmacology. 86: 12-21. PMID 3764931 DOI: 10.1016/0041-008X(86)90395-9  0.342
1984 Hobson JF, Carter DE, Lightner DV. Toxicity of a phthalate ester in the diet of a penaied shrimp Journal of Toxicology and Environmental Health. 13: 959-968. PMID 6492211 DOI: 10.1080/15287398409530553  0.34
1984 Webb DR, Sipes IG, Carter DE. In vitro solubility and in vivo toxicity of gallium arsenide Toxicology and Applied Pharmacology. 76: 96-104. PMID 6484996 DOI: 10.1016/0041-008X(84)90032-2  0.41
1984 Stine ER, Hsu CA, Hoover TD, Aposhian HV, Carter DE. N-(2,3-dimercaptopropyl)phthalamidic acid: protection, in vivo and in vitro, against arsenic intoxication. Toxicology and Applied Pharmacology. 75: 329-36. PMID 6474464 DOI: 10.1016/0041-008X(84)90215-1  0.319
1984 Volp RF, Sipes IG, Falcoz C, Carter DE, Gross JF. Disposition of 1,2,3-trichloropropane in the fischer 344 rat: Conventional and physiological pharmacokinetics Toxicology and Applied Pharmacology. 75: 8-17. PMID 6431641 DOI: 10.1016/0041-008X(84)90070-X  0.385
1984 Ryerson BA, Carter DE, Sipes IG. Comparison of 2,2′,4,4′,5,5′-hexachloro[14C]biphenyl levels in different adipose tissues of dogs and monkeys Fundamental and Applied Toxicology. 4: 120-124. PMID 6420218 DOI: 10.1016/0272-0590(84)90225-2  0.302
1984 Aposhian HV, Carter DE, Hoover TD, Hsu CA, Maiorino RM, Stine E. DMSA, DMPS, and DMPA--as arsenic antidotes. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 4: S58-70. PMID 6327446 DOI: 10.1016/0272-0590(84)90138-6  0.344
1982 Miller MJ, Carter DE, Sipes IG. Pharmacokinetics of acrylamide in Fisher-334 rats Toxicology and Applied Pharmacology. 63: 36-44. PMID 7071872 DOI: 10.1016/0041-008X(82)90024-2  0.395
1982 Sipes IG, Slocumb ML, Perry DF, Carter DE. 2,4,5,2′,4′,5′-Hexachlorobiphenyl: Distribution, metabolism, and excretion in the dog and the monkey Toxicology and Applied Pharmacology. 65: 264-272. PMID 6817469 DOI: 10.1016/0041-008X(82)90009-6  0.374
1980 Sipes IG, Slocumb ML, Perry DF, Carter DE. 4,4'-Dichlorobiphenyl: Distribution, metabolism, and excretion in the dog and the monkey Toxicology and Applied Pharmacology. 55: 554-563. PMID 6776653 DOI: 10.1016/0041-008X(80)90057-5  0.371
1979 Zimmer L, Carter DE. Effects of complexing treatment administered with the onset of methyl mercury neurotoxic signs Toxicology and Applied Pharmacology. 51: 29-38. PMID 524372 DOI: 10.1016/0041-008X(79)90005-X  0.342
1978 Zimmer LJ, Carter DE. The efficacy of 2,3-dimercaptopropanol and D-penicillamine on methyl mercury induced neurological signs and weight loss Life Sciences. 23: 1025-1034. PMID 713681 DOI: 10.1016/0024-3205(78)90662-8  0.333
1977 Halladay SC, Glenn Sipes I, Carter DE. Diuretic effect and metabolism of bumetanide in man Clinical Pharmacology and Therapeutics. 22: 179-187. PMID 884919 DOI: 10.1002/Cpt1977222179  0.36
1975 Halladay SC, Carter DE, Sipes IG, Brodie BB, Bressler R. Evidence for the metabolism of bumetanide in man. Life Sciences. 17: 1003-9. PMID 1195984 DOI: 10.1016/0024-3205(75)90455-5  0.328
1974 Carter DE, Goldman JM, Bressler R, Huxtable RJ, Christian CD, Heine MW. Effect of oral contraceptives on drug metabolism. Clinical Pharmacology and Therapeutics. 15: 22-31. PMID 4808741 DOI: 10.1002/Cpt197415122  0.342
Show low-probability matches.